PMA device
Visioncare Implantable Miniature Telescope
Samsara Vision, Inc. · Telescope, Implantable, Miniature (NCJ, Class III) · First FDA decision Jan 27, 2015, newest Jan 27, 2015Macular degeneration and retinal disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "Visioncare"
MAUDE reports
0
Brand "Visioncare", since 2015
PubMed studies
11
Mentioning "Visioncare"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Visioncare Implantable Miniature Telescope
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- VISIONCARE IMPLANTABLE MINIATURE TELESCOPEPMA supplement
P050034-S015 · Decided Jan 27, 2015 · 60 days after receipt · Normal 180 Day Track No User Fee
Device type: Telescope, implantable, miniature (NCJ) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Visioncare", any status and sponsor, newest update first.
- The Effect of Myopia-Control Contact Lenses in New Zealand Chinese ChildrenActive, not recruiting
Aston UniversityAcademic, hospital or other
NCT07535749 · 66 participants (planned) · Start Mar 21, 2026 · Primary completion Apr 30, 2027
Device: MiSight Contact Lenses (CooperVision); Albiliti 1-Day (Johnson and Johnson, VisionCare) · For: Myopia Progression
Sites: Auckland, New Zealand
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Visioncare", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NCJ
3 reports: 1 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Visioncare"[tiab]. The summary above synthesizes these.
- A Discussion of Commercially Available Intra-ocular Telescopic Implants for Patients with Age-Related Macular Degeneration.
Dunbar HMP, Dhawahir-Scala FE · Ophthalmol Ther · 2018Review
- Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants.
Singer MA, Amir N, Herro A, et al. · Clin Ophthalmol · 2012
- Visual performance, light distortion and patient reported outcomes with a new bi-aspheric non-diffractive extended depth of focus intraocular lens.
Tañá-Sanz S, Tañá-Sanz P, Elvira-Giner B, et al. · Front Med (Lausanne) · 2025
- Dryness and discomfort with silicone hydrogel contact lenses.
Fonn D, Dumbleton K · Eye Contact Lens · 2003Clinical Trial, Comparative Study
- Re: Children's Eye Screening South Australia (CESSA): diagnostic performance of a vision screening programme for 7-9-year-olds.
Babu L, Sharma S, Chanu TZ, et al. · Clin Exp Optom · 2026
- Balanced Extended Vision Procedure: Preclinical Analysis of a Non-diffractive Approach to Full Range of Vision After Cataract Surgery.
Dick HB, Chiu YF, Yang CH, et al. · J Refract Surg · 2026Comparative Study
- Time's ticking! Effects of deadline on the utilization of health services: Evidence from a cluster-randomized controlled trial.
Guan H, Yang T, Zhang Y, et al. · Soc Sci Med · 2023
- Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.
Hudson HL, Lane SS, Heier JS, et al. · Ophthalmology · 2006Controlled Clinical Trial, Multicenter Study
- ICEE/AHMRC NSW Aboriginal Eye and Visioncare Program, Australia.
Layland B, Holden B, Evans K, et al. · Rural Remote Health · 2004
- Multilevel Assessment of Middle School Students' Interest in the Health Sciences: Development and Validation of a New Measurement Tool.
Romine WL, Miller ME, Knese SA, et al. · CBE Life Sci Educ · 2016Research Support, Non-U.S. Gov't, Validation Study
- A Cross-Sectional Study on the Prevalence, Risk Factors, and Impact of Myopia Among Medical Students in Andhra Pradesh, India.
Manchikanty SRCM, M JSR, C U, et al. · Cureus · 2025
Other devices of this type
Also filed under product code NCJ.
- Implantable Miniature Telescope (IMT)Samsara Vision, Inc. · PMA 2024
- Visioncare's Implantable Miniature TelescopeSamsara Vision, Inc. · PMA 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.